Home Posts tagged CytoReason

CYTOREASON

AI Tech Trends

Israeli AI medical startup CytoReason secures funding from Nvidia

Vicky Wu July 19, 2024

CytoReason has secured $80 million investment from OurCrowd, Nvidia, Pfizer, and Thermo Fisher Scientific.

Vicky Wu

Vicky is an intern reporter at Blue Tech Wave specialising in AI and Blockchain. She graduated from Dalian University of Foreign Languages. Send tips to v.wu@btw.media.

Leave a Reply Cancel reply

Blue Tech Wave Media (BTW.Media) is a dynamic media company, recognized as one of the top tech news sites for its cutting-edge coverage of the latest trends and innovations in the tech industry. Our dedicated team of experienced journalists, analysts, and storytellers consistently delivers timely, engaging content that provides the insights you need to stay ahead in the ever-evolving world of technology. As one of the top tech news sites, BTW.Media keeps you informed and connected. Follow us on all major social media platforms for updates. BTW Media is proudly owned by LARUS Ltd.

Can we store cookies?

We use cookies to enhance services, personalize content, and analyze traffic. This involves sharing data with social media, advertising, and analytics partners. By using our website, you agree to the placement of cookies as described in our Cookie Policy. Learn more about our use of cookies and your choices in our Cookie Policy

Accept All

Decline All

CYTOREASON

Israeli AI medical startup CytoReason secures funding from Nvidia

Popular Posts

Where did the metaverse go? And will Apple’s Vision Pro bring it back?

What is a Regional Internet Registry?

Carbon trading explained: Top 4 carbon emission exchanges in 2024

How criminals used AI face apps to swindle users: A China case study exposes the risks

What are IP addresses and why they are important?

Leave a Reply Cancel reply

Our biggest stories, delivered to your inbox every week.

About us

Contact us

Can we store cookies?